Health-care stocks make up about 12% of Standard & PoorUs 500-stock index, so putting at least that much of your U.S. stock portfolio in the sector makes sense. But if you're shopping for a health-care sector fund, keep in mind that other funds in your portfolio probably have a big dose of health stocks already, so factor that into your calculations.
Our favorite health-care fund is T. Rowe Price Health Sciences (symbol PRHSX; 800-638-5660). Under manager Kris Jenner, a graduate of Johns Hopkins School of Medicine, the no-load fund posted an annualized return of 18% over the past five years to October 1, outpacing the Dow Jones Health Care index by an average of eight percentage points per year.
Large drug companies dominate the major health-care indexes, and just two stocks, Johnson & Johnson and Pfizer, account for as much as 20% of some measures. Jenner's portfolio, by contrast, tilts toward midsize firms. Roughly one-third of the fund is invested in biotech stocks, and its allocation to Big Pharma is low, at about 25% of assets. We think that's about right. The fund charges a reasonable 0.87% annually to cover expenses.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Schwab Health Care (SWHFX; 800-435-4000), which uses a computer model to pick stocks, is another top-performing, low-cost fund. Lately, the model has been favoring shares of large companies, and Big Pharma dominates the top ten holdings, which make up about half the fund's assets (Schering-Plough, Merck and Pfizer are among the four biggest holdings). But it's hard to argue with the fund's record -- a 19% annualized return over five years. The expense ratio is 0.84%.
If you prefer an indexed approach to health stocks, we suggest two cheap exchange-traded funds. Annual expenses for Vanguard Health Care (VHT) and Health Care Select Sector SPDR (XLV) are 0.25% and 0.24%, respectively. SPDR S&P Biotech (XBI) is a good way to add some biotech to your existing health-care holdings, but donUt get carried away. A 5% allocation is more than enough for most investors. The fund charges 0.35% annually for expenses.
-
What’s the Difference Between a CPA and a Tax Planner?CPAs do the important number crunching for tax preparation and filing, but tax planners look at the big picture and come up with tax-saving strategies.
-
Starbucks BOGO and New Sweet and Spicy DrinksFor a limited time, Starbucks is announcing four new "swicy" drinks that are both spicy and sweet.
-
Best Banks for High-Net-Worth Clientswealth management Kiplinger's 2023 list of the best banks for higher-net-worth clients.
-
Stock Market Holidays in 2024: NYSE, NASDAQ and Wall Street HolidaysMarkets When are the stock market holidays? Take a look at which days the NYSE, Nasdaq and bond markets are off in 2024.
-
Stock Market Trading Hours: What Time Is the Stock Market Open Today?Markets When does the market open? It's true the stock market does have regular hours, but trading doesn't necessarily stop when the major exchanges close.
-
Bogleheads Stay the CourseBears and market volatility don’t scare these die-hard Vanguard investors.
-
I-Bond Rate Is 5.27% for Next Six MonthsInvesting for Income I-Bonds issued November 1, 2023 through April 30, 2024 will have a rate of 5.27%.
-
What Are I-Bonds?savings bonds Inflation has made Series I savings bonds enormously popular with risk-averse investors. So how do they work?
-
This New Sustainable ETF’s Pitch? Give Back Profits.investing Newday’s ETF partners with UNICEF and other groups.
-
As the Market Falls, New Retirees Need a Planretirement If you’re in the early stages of your retirement, you’re likely in a rough spot watching your portfolio shrink. We have some strategies to make the best of things.
